Compare DexCom, Inc. (DXCM) vs Etsy Inc (ETSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Etsy Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Etsy Inc trades at $76.71 (market cap $6.90B). The key difference: DexCom, Inc. is far larger — about 4.6× Etsy Inc's market cap, and DexCom, Inc. is more actively traded (3,607,070 versus 2,923,867). Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Etsy Inc for 67 Days on average.
| DXCM | ETSY | |
|---|---|---|
Market Cap | $31.86B | $6.90B |
Volume | 3,607,070 | 2,923,867 |
Sector | Health | Consumer Cyclical |
52-Week High | $92.34 | $87.03 |
52-Week Low | $54.84 | $44.05 |
Typical Hold Time | 62 Days | 67 Days |
Enterprise Value | $31.32B | $8.85B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
ETSY trades at $75.14, up 5.11% today, showing strong momentum with three consecutive earnings beats. The stock maintains a bullish technical outlook with support at $73 and resistance at $76. Fundamentally, revenue growth has been steady at $2.9B annually, though net margins compressed to 5.65% in 2025. Recent news highlights AI integration and payment partnerships as growth catalysts.
The outlook remains positive with a $85.94 analyst price target suggesting 14% upside. Key risks include high debt levels and competitive pressures. Wall Street sentiment is bullish (53% buy ratings), but investors should monitor margin trends and execution of AI initiatives for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
